Share Price and Basic Stock Data
Last Updated: November 28, 2025, 10:27 am
| PEG Ratio | 0.30 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Bhaskar Agrochemicals Ltd operates within the agrochemicals sector, focusing on the production and distribution of pesticides. The company’s market capitalization stood at ₹65.5 Cr, and its share price was recorded at ₹126. Over the past fiscal years, Bhaskar Agrochemicals has demonstrated fluctuating revenue trends. Sales for the year ending March 2023 were ₹55 Cr, with a notable increase to ₹67 Cr in March 2024. The trailing twelve months (TTM) figure rose to ₹102 Cr, indicating a positive growth trajectory. Quarterly revenue figures highlight seasonal variations; for instance, sales peaked at ₹32.24 Cr in September 2024, while the lowest quarterly revenue was ₹5.36 Cr in June 2022. This volatility suggests that the company is highly sensitive to market conditions and agricultural cycles, which is common in the agrochemicals industry. The increasing TTM sales reflect a recovery trend, suggesting that Bhaskar Agrochemicals is capitalizing on growing agricultural demands.
Profitability and Efficiency Metrics
Profitability metrics for Bhaskar Agrochemicals reveal a mixed performance. The operating profit margin (OPM) stood at 3.15%, which is relatively low compared to industry standards, indicating challenges in managing operational costs. The company recorded an operating profit of ₹9 Cr for the fiscal year ending March 2025, up from ₹5 Cr in March 2023. However, the net profit for the same period was ₹4 Cr, highlighting significant expenses impacting the bottom line. The return on equity (ROE) was a commendable 24.7%, while return on capital employed (ROCE) stood at 21.3%, suggesting efficient use of equity and capital. The interest coverage ratio (ICR) of 4.56x indicates that the company comfortably meets its interest obligations, which is a positive sign for investors. However, the cash conversion cycle (CCC) of 155 days suggests inefficiencies in managing inventory and receivables, which could impact liquidity if not addressed.
Balance Sheet Strength and Financial Ratios
Bhaskar Agrochemicals maintains a sound balance sheet with no reported borrowings, which reflects a conservative financial strategy. The absence of debt allows the company to operate without interest burdens, as evidenced by the reported interest coverage ratio of 4.56x. The price-to-book value (P/BV) ratio was recorded at 2.29x, indicating that the market values the shares at a premium relative to the book value. The book value per share increased to ₹34.07 in March 2025, a significant rise from ₹26.58 in the previous year, which speaks to the company’s growth and retained earnings. Additionally, the total debt-to-equity ratio stood at 1.14, suggesting a balanced approach to leverage. However, the current ratio of 1.20 indicates that while the company has enough current assets to cover its liabilities, the liquidity position could be tightened, especially with the high cash conversion cycle. The profitability ratios, including net profit margin of 4.30%, reflect improvement but still suggest room for operational efficiency enhancements.
Shareholding Pattern and Investor Confidence
The shareholding structure of Bhaskar Agrochemicals indicates strong promoter confidence, with promoters holding 62.28% of the shares as of June 2025. This stable ownership by insiders can instill confidence in other investors, as it suggests that those with the most significant stake in the company are committed to its long-term success. The public shareholding stood at 37.72%, showing a balanced distribution of ownership. The number of shareholders increased from 3,871 in December 2022 to 4,552 by June 2025, reflecting growing interest in the company among retail investors. However, the lack of foreign institutional investors (FIIs) and domestic institutional investors (DIIs) suggests that institutional confidence may be limited, potentially impacting stock liquidity and broader market support. This could pose a risk if the company seeks to raise capital or expand operations, as institutional backing often provides additional stability and credibility.
Outlook, Risks, and Final Insight
Looking ahead, Bhaskar Agrochemicals has several strengths and risks to consider. The company’s strong ROE and ROCE metrics suggest efficient capital utilization, which is a positive indicator for future profitability. However, the ongoing challenges related to its cash conversion cycle and low operating margins could hinder growth if not effectively managed. The absence of debt is a significant advantage, providing financial flexibility; however, reliance on seasonal agricultural demand poses risks associated with market volatility. If the company successfully enhances operational efficiencies and capitalizes on the growing demand for agricultural products, it could significantly improve its profitability and market positioning. Conversely, adverse weather conditions or changes in agricultural policies may pose threats to revenue stability. Overall, Bhaskar Agrochemicals’ outlook appears cautiously optimistic, contingent on its ability to address operational challenges and leverage its market position effectively.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Bhaskar Agrochemicals Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Epigral Ltd | 6,451 Cr. | 1,495 | 2,196/1,398 | 16.0 | 487 | 0.40 % | 24.9 % | 22.3 % | 10.0 |
| Dharmaj Crop Guard Ltd | 828 Cr. | 245 | 391/165 | 17.0 | 131 | 0.00 % | 12.0 % | 9.28 % | 10.0 |
| Bhaskar Agrochemicals Ltd | 64.6 Cr. | 124 | 149/56.6 | 11.6 | 40.0 | 0.00 % | 21.3 % | 24.7 % | 10.0 |
| Bhagiradha Chemicals & Industries Ltd | 3,209 Cr. | 248 | 365/228 | 121 | 54.9 | 0.06 % | 7.44 % | 4.91 % | 1.00 |
| Best Agrolife Ltd | 916 Cr. | 387 | 670/244 | 71.5 | 342 | 0.76 % | 12.9 % | 9.95 % | 10.0 |
| Industry Average | 11,228.70 Cr | 1,496.67 | 33.19 | 472.46 | 0.43% | 15.21% | 19.87% | 7.25 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5.36 | 23.21 | 16.90 | 11.09 | 7.33 | 29.55 | 20.29 | 9.48 | 11.66 | 32.24 | 24.30 | 22.31 | 23.20 |
| Expenses | 5.87 | 19.56 | 14.18 | 11.92 | 9.19 | 24.27 | 17.25 | 9.87 | 13.18 | 26.89 | 20.91 | 20.49 | 22.47 |
| Operating Profit | -0.51 | 3.65 | 2.72 | -0.83 | -1.86 | 5.28 | 3.04 | -0.39 | -1.52 | 5.35 | 3.39 | 1.82 | 0.73 |
| OPM % | -9.51% | 15.73% | 16.09% | -7.48% | -25.38% | 17.87% | 14.98% | -4.11% | -13.04% | 16.59% | 13.95% | 8.16% | 3.15% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.02 | 0.00 | 0.01 | 0.06 | 0.00 |
| Interest | 0.39 | 0.41 | 0.44 | 0.47 | 0.48 | 0.46 | 0.46 | 0.47 | 0.44 | 0.37 | 0.45 | 0.74 | 0.48 |
| Depreciation | 0.29 | 0.30 | 0.30 | 0.31 | 0.36 | 0.41 | 0.40 | 0.41 | 0.42 | 0.43 | 0.44 | 0.45 | 0.43 |
| Profit before tax | -1.19 | 2.94 | 1.98 | -1.61 | -2.70 | 4.41 | 2.18 | -1.23 | -2.36 | 4.55 | 2.51 | 0.69 | -0.18 |
| Tax % | 62.18% | 28.91% | 28.79% | -32.92% | -24.81% | 27.66% | 32.11% | -27.64% | -24.15% | 30.33% | 29.08% | -7.25% | 16.67% |
| Net Profit | -1.94 | 2.10 | 1.41 | -1.08 | -2.03 | 3.19 | 1.48 | -0.90 | -1.78 | 3.17 | 1.77 | 0.74 | -0.21 |
| EPS in Rs | -3.72 | 4.03 | 2.71 | -2.07 | -3.90 | 6.12 | 2.84 | -1.73 | -3.42 | 6.08 | 3.40 | 1.42 | -0.40 |
Last Updated: August 19, 2025, 10:15 pm
Below is a detailed analysis of the quarterly data for Bhaskar Agrochemicals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 23.20 Cr.. The value appears strong and on an upward trend. It has increased from 22.31 Cr. (Mar 2025) to 23.20 Cr., marking an increase of 0.89 Cr..
- For Expenses, as of Jun 2025, the value is 22.47 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 20.49 Cr. (Mar 2025) to 22.47 Cr., marking an increase of 1.98 Cr..
- For Operating Profit, as of Jun 2025, the value is 0.73 Cr.. The value appears to be declining and may need further review. It has decreased from 1.82 Cr. (Mar 2025) to 0.73 Cr., marking a decrease of 1.09 Cr..
- For OPM %, as of Jun 2025, the value is 3.15%. The value appears to be declining and may need further review. It has decreased from 8.16% (Mar 2025) to 3.15%, marking a decrease of 5.01%.
- For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.06 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 0.06 Cr..
- For Interest, as of Jun 2025, the value is 0.48 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.74 Cr. (Mar 2025) to 0.48 Cr., marking a decrease of 0.26 Cr..
- For Depreciation, as of Jun 2025, the value is 0.43 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.45 Cr. (Mar 2025) to 0.43 Cr., marking a decrease of 0.02 Cr..
- For Profit before tax, as of Jun 2025, the value is -0.18 Cr.. The value appears to be declining and may need further review. It has decreased from 0.69 Cr. (Mar 2025) to -0.18 Cr., marking a decrease of 0.87 Cr..
- For Tax %, as of Jun 2025, the value is 16.67%. The value appears to be increasing, which may not be favorable. It has increased from -7.25% (Mar 2025) to 16.67%, marking an increase of 23.92%.
- For Net Profit, as of Jun 2025, the value is -0.21 Cr.. The value appears to be declining and may need further review. It has decreased from 0.74 Cr. (Mar 2025) to -0.21 Cr., marking a decrease of 0.95 Cr..
- For EPS in Rs, as of Jun 2025, the value is -0.40. The value appears to be declining and may need further review. It has decreased from 1.42 (Mar 2025) to -0.40, marking a decrease of 1.82.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:46 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 27 | 26 | 28 | 28 | 52 | 52 | 52 | 64 | 62 | 55 | 67 | 91 | 102 |
| Expenses | 26 | 25 | 26 | 26 | 50 | 49 | 49 | 61 | 57 | 50 | 61 | 81 | 91 |
| Operating Profit | 1 | 1 | 2 | 2 | 2 | 3 | 3 | 3 | 5 | 5 | 6 | 9 | 11 |
| OPM % | 5% | 5% | 7% | 8% | 4% | 6% | 6% | 5% | 8% | 9% | 9% | 10% | 11% |
| Other Income | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 |
| Depreciation | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
| Profit before tax | 1 | 1 | 2 | 1 | 0 | 1 | 1 | 1 | 2 | 2 | 3 | 5 | 8 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 44% | 88% | 34% | 28% | |
| Net Profit | 1 | 1 | 2 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 2 | 4 | 5 |
| EPS in Rs | 2.63 | 2.02 | 3.03 | 1.65 | 0.75 | 1.38 | 1.17 | 1.63 | 2.09 | 0.44 | 3.34 | 7.49 | 10.50 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 0.00% | 100.00% | -50.00% | -100.00% | 0.00% | 0.00% | 0.00% | -100.00% | 100.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | 100.00% | -150.00% | -50.00% | 100.00% | 0.00% | 0.00% | -100.00% | 200.00% |
Bhaskar Agrochemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 12% |
| 3 Years: | 13% |
| TTM: | 44% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 45% |
| 3 Years: | 40% |
| TTM: | 175% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 55% |
| 3 Years: | 43% |
| 1 Year: | 70% |
| Return on Equity | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 13% |
| 3 Years: | 14% |
| Last Year: | 25% |
Last Updated: September 5, 2025, 2:41 pm
No data available for the Balance Sheet data table.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 3 | 7 | 10 | 7 | 8 | 20 | 38 | 20 | 76 | 111 | 82 | 86 |
| Inventory Days | 66 | 73 | 73 | 97 | 65 | 75 | 48 | 66 | 109 | 114 | 142 | 133 |
| Days Payable | 51 | 65 | 34 | 39 | 28 | 34 | 30 | 71 | 91 | 108 | 97 | 64 |
| Cash Conversion Cycle | 18 | 15 | 49 | 65 | 45 | 61 | 56 | 15 | 95 | 116 | 128 | 155 |
| Working Capital Days | -16 | -19 | -28 | -43 | -31 | -39 | -36 | -17 | 4 | 6 | 22 | 26 |
| ROCE % | 20% | 14% | 17% | 12% | 8% | 10% | 9% | 11% | 17% | 12% | 15% | 21% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 7.48 | 3.34 | 0.45 | 2.09 | 1.63 |
| Diluted EPS (Rs.) | 7.48 | 3.34 | 0.45 | 2.09 | 1.63 |
| Cash EPS (Rs.) | 10.82 | 6.40 | 2.77 | 4.26 | 3.60 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 34.07 | 26.58 | 23.22 | 22.71 | 19.69 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 34.07 | 26.58 | 23.22 | 22.71 | 19.69 |
| Revenue From Operations / Share (Rs.) | 173.73 | 128.21 | 106.30 | 125.72 | 122.77 |
| PBDIT / Share (Rs.) | 17.54 | 11.74 | 9.18 | 9.99 | 6.18 |
| PBIT / Share (Rs.) | 14.21 | 8.70 | 6.86 | 7.82 | 4.21 |
| PBT / Share (Rs.) | 10.37 | 5.10 | 3.57 | 3.74 | 1.63 |
| Net Profit / Share (Rs.) | 7.48 | 3.35 | 0.45 | 2.09 | 1.63 |
| PBDIT Margin (%) | 10.09 | 9.16 | 8.63 | 7.94 | 5.03 |
| PBIT Margin (%) | 8.17 | 6.78 | 6.44 | 6.22 | 3.43 |
| PBT Margin (%) | 5.96 | 3.98 | 3.36 | 2.97 | 1.33 |
| Net Profit Margin (%) | 4.30 | 2.61 | 0.42 | 1.66 | 1.33 |
| Return on Networth / Equity (%) | 21.95 | 12.60 | 1.94 | 9.21 | 8.29 |
| Return on Capital Employeed (%) | 29.23 | 19.67 | 18.20 | 23.01 | 14.20 |
| Return On Assets (%) | 6.67 | 3.48 | 0.49 | 2.47 | 2.69 |
| Long Term Debt / Equity (X) | 0.25 | 0.25 | 0.23 | 0.15 | 0.28 |
| Total Debt / Equity (X) | 1.14 | 1.09 | 1.29 | 1.12 | 0.74 |
| Asset Turnover Ratio (%) | 1.67 | 1.37 | 1.21 | 1.73 | 2.09 |
| Current Ratio (X) | 1.20 | 0.58 | 1.03 | 1.02 | 0.81 |
| Quick Ratio (X) | 0.65 | 0.58 | 0.61 | 0.51 | 0.24 |
| Inventory Turnover Ratio (X) | 0.00 | 7.97 | 3.24 | 4.73 | 7.71 |
| Interest Coverage Ratio (X) | 4.56 | 3.27 | 2.80 | 3.78 | 2.39 |
| Interest Coverage Ratio (Post Tax) (X) | 2.95 | 1.93 | 1.14 | 2.34 | 1.63 |
| Enterprise Value (Cr.) | 60.74 | 48.27 | 55.23 | 49.51 | 26.33 |
| EV / Net Operating Revenue (X) | 0.67 | 0.72 | 0.99 | 0.75 | 0.41 |
| EV / EBITDA (X) | 6.65 | 7.91 | 11.58 | 9.54 | 8.20 |
| MarketCap / Net Operating Revenue (X) | 0.44 | 0.46 | 0.67 | 0.50 | 0.26 |
| Price / BV (X) | 2.29 | 2.22 | 3.09 | 2.81 | 1.63 |
| Price / Net Operating Revenue (X) | 0.44 | 0.46 | 0.67 | 0.50 | 0.26 |
| EarningsYield | 0.09 | 0.05 | 0.01 | 0.03 | 0.05 |
After reviewing the key financial ratios for Bhaskar Agrochemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 7.48. This value is within the healthy range. It has increased from 3.34 (Mar 24) to 7.48, marking an increase of 4.14.
- For Diluted EPS (Rs.), as of Mar 25, the value is 7.48. This value is within the healthy range. It has increased from 3.34 (Mar 24) to 7.48, marking an increase of 4.14.
- For Cash EPS (Rs.), as of Mar 25, the value is 10.82. This value is within the healthy range. It has increased from 6.40 (Mar 24) to 10.82, marking an increase of 4.42.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 34.07. It has increased from 26.58 (Mar 24) to 34.07, marking an increase of 7.49.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 34.07. It has increased from 26.58 (Mar 24) to 34.07, marking an increase of 7.49.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 173.73. It has increased from 128.21 (Mar 24) to 173.73, marking an increase of 45.52.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 17.54. This value is within the healthy range. It has increased from 11.74 (Mar 24) to 17.54, marking an increase of 5.80.
- For PBIT / Share (Rs.), as of Mar 25, the value is 14.21. This value is within the healthy range. It has increased from 8.70 (Mar 24) to 14.21, marking an increase of 5.51.
- For PBT / Share (Rs.), as of Mar 25, the value is 10.37. This value is within the healthy range. It has increased from 5.10 (Mar 24) to 10.37, marking an increase of 5.27.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 7.48. This value is within the healthy range. It has increased from 3.35 (Mar 24) to 7.48, marking an increase of 4.13.
- For PBDIT Margin (%), as of Mar 25, the value is 10.09. This value is within the healthy range. It has increased from 9.16 (Mar 24) to 10.09, marking an increase of 0.93.
- For PBIT Margin (%), as of Mar 25, the value is 8.17. This value is below the healthy minimum of 10. It has increased from 6.78 (Mar 24) to 8.17, marking an increase of 1.39.
- For PBT Margin (%), as of Mar 25, the value is 5.96. This value is below the healthy minimum of 10. It has increased from 3.98 (Mar 24) to 5.96, marking an increase of 1.98.
- For Net Profit Margin (%), as of Mar 25, the value is 4.30. This value is below the healthy minimum of 5. It has increased from 2.61 (Mar 24) to 4.30, marking an increase of 1.69.
- For Return on Networth / Equity (%), as of Mar 25, the value is 21.95. This value is within the healthy range. It has increased from 12.60 (Mar 24) to 21.95, marking an increase of 9.35.
- For Return on Capital Employeed (%), as of Mar 25, the value is 29.23. This value is within the healthy range. It has increased from 19.67 (Mar 24) to 29.23, marking an increase of 9.56.
- For Return On Assets (%), as of Mar 25, the value is 6.67. This value is within the healthy range. It has increased from 3.48 (Mar 24) to 6.67, marking an increase of 3.19.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.25. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.25.
- For Total Debt / Equity (X), as of Mar 25, the value is 1.14. This value exceeds the healthy maximum of 1. It has increased from 1.09 (Mar 24) to 1.14, marking an increase of 0.05.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.67. It has increased from 1.37 (Mar 24) to 1.67, marking an increase of 0.30.
- For Current Ratio (X), as of Mar 25, the value is 1.20. This value is below the healthy minimum of 1.5. It has increased from 0.58 (Mar 24) to 1.20, marking an increase of 0.62.
- For Quick Ratio (X), as of Mar 25, the value is 0.65. This value is below the healthy minimum of 1. It has increased from 0.58 (Mar 24) to 0.65, marking an increase of 0.07.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 4. It has decreased from 7.97 (Mar 24) to 0.00, marking a decrease of 7.97.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 4.56. This value is within the healthy range. It has increased from 3.27 (Mar 24) to 4.56, marking an increase of 1.29.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.95. This value is below the healthy minimum of 3. It has increased from 1.93 (Mar 24) to 2.95, marking an increase of 1.02.
- For Enterprise Value (Cr.), as of Mar 25, the value is 60.74. It has increased from 48.27 (Mar 24) to 60.74, marking an increase of 12.47.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.67. This value is below the healthy minimum of 1. It has decreased from 0.72 (Mar 24) to 0.67, marking a decrease of 0.05.
- For EV / EBITDA (X), as of Mar 25, the value is 6.65. This value is within the healthy range. It has decreased from 7.91 (Mar 24) to 6.65, marking a decrease of 1.26.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 1. It has decreased from 0.46 (Mar 24) to 0.44, marking a decrease of 0.02.
- For Price / BV (X), as of Mar 25, the value is 2.29. This value is within the healthy range. It has increased from 2.22 (Mar 24) to 2.29, marking an increase of 0.07.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 1. It has decreased from 0.46 (Mar 24) to 0.44, marking a decrease of 0.02.
- For EarningsYield, as of Mar 25, the value is 0.09. This value is below the healthy minimum of 5. It has increased from 0.05 (Mar 24) to 0.09, marking an increase of 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Bhaskar Agrochemicals Ltd:
- Net Profit Margin: 4.3%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 29.23% (Industry Average ROCE: 15.21%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 21.95% (Industry Average ROE: 19.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.95
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.65
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 11.6 (Industry average Stock P/E: 33.19)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.14
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 4.3%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Agro Chemicals/Pesticides | D. No.1-90/C, Office Unit-608,1T06, 6th Floor. Gowra Fountain Head, Hyderabad Telangana 500081 | bhaskaragro@yahoo.com http://www.bhaskaragro.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. P Pattabhi Rama Rao | Chairman & Managing Director |
| Mr. P Praveen Kumar | Joint Managing Director & CFO |
| Dr. Aluri Naga Uma Maheswara Prasad | Non Executive Director |
| Mrs. P Rajyalaxmi | Non Executive Director |
| Mr. S V Satyanarayana Chowdary | Independent Director |
| Mr. Sudhakar | Independent Director |